Keen Vision Acquisition Corporation Ordinary Shares (KVAC) Dividend History

Keen Vision Acquisition Corporation (KVAC) is a special purpose acquisition company (SPAC) formed to identify and acquire businesses in the technology sector. Its primary objective is to facilitate a merger or acquisition that aligns with its strategic focus, offering investors a pathway to gain exposure to innovative companies through a liquidity event. As a blank-check company, KVAC does not have commercial operations prior to its planned merger or acquisition.

37 Greenbriar Drive, Summit, NJ, 07901
Phone: (203) 609-1394

Dividend History

Keen Vision Acquisition Corporation Ordinary Shares currently does not pay dividends

Company News

$HAREHOLDER ALERT: The M&A Class Action Firm Continues To Investigate The Merger – NHHS, KVAC, AMPS, AVTE

The M&A Class Action Firm is investigating the proposed mergers of NorthStar Healthcare Income, Keen Vision Acquisition Corp., Altus Power, and Aerovate Therapeutics, providing information and options for shareholders.

GlobeNewswire Inc.
Medera Completes Patient Dosing in Phase 1/2a MUSIC-HFrEF Trial of SRD-001 Gene Therapy for Heart Failure with Reduced Ejection Fraction

Medera, a clinical-stage biopharmaceutical company, has completed patient dosing in its Phase 1/2a MUSIC-HFrEF trial of the gene therapy candidate SRD-001 for heart failure with reduced ejection fraction. The preliminary data showed an acceptable safety profile and clinically meaningful improvements in heart function and patient health.

Benzinga

Page data last updated 08/19/2025 17:04:12 UTC